Detailed information for compound 303234

Basic information

Technical information
  • TDR Targets ID: 303234
  • Name: 5-acetamido-8-aminonaphthalene-2-sulfonic aci d
  • MW: 280.3 | Formula: C12H12N2O4S
  • H donors: 3 H acceptors: 4 LogP: 0.42 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)Nc1ccc(c2c1ccc(c2)S(=O)(=O)O)N
  • InChi: 1S/C12H12N2O4S/c1-7(15)14-12-5-4-11(13)10-6-8(19(16,17)18)2-3-9(10)12/h2-6H,13H2,1H3,(H,14,15)(H,16,17,18)
  • InChiKey: HHZJYPDSTRLGEP-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 5-acetamido-8-amino-naphthalene-2-sulfonic acid
  • 5-acetamido-8-amino-2-naphthalenesulfonic acid
  • 5-acetamido-8-azanyl-naphthalene-2-sulfonic acid
  • 85-80-3
  • AIDS-080747
  • NSC 37078
  • 2-Naphthalenesulfonic acid, 5-(acetylamino)-8-amino-
  • 2-Naphthalenesulfonic acid, 5-acetamido-8-amino-
  • NSC37078
  • AIDS080747
  • 5-Acetylamino-8-aminonaphthalene-2-sulfonic acid

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 integrase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni hypothetical protein Get druggable targets OG5_139608 All targets in OG5_139608
Trypanosoma brucei RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
Trypanosoma congolense RNA helicase, putative Get druggable targets OG5_139608 All targets in OG5_139608
Plasmodium yoelii integrase-related Get druggable targets OG5_139608 All targets in OG5_139608
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium ulcerans lipase LipU 0.0204 0.0066 0.5
Onchocerca volvulus 0.0204 0.0066 0.5
Mycobacterium leprae Possible lipase LipU 0.0204 0.0066 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.2041 1 1
Leishmania major hypothetical protein, conserved 0.0204 0.0066 0.5
Mycobacterium tuberculosis Putative acetyl hydrolase MbtJ 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable carboxylesterase LipQ 0.0204 0.0066 0.5
Mycobacterium ulcerans esterase LipW 0.0204 0.0066 0.5
Brugia malayi aryl-acylamidase 0.0204 0.0066 0.5
Loa Loa (eye worm) hypothetical protein 1.2041 1 1
Mycobacterium ulcerans carboxylesterase LipQ 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable esterase LipO 0.0204 0.0066 0.5
Mycobacterium ulcerans esterase LipO 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable non lipolytic carboxylesterase NlhH 0.0204 0.0066 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.2041 1 1
Trichomonas vaginalis Esterase, putative 0.0204 0.0066 0.5
Toxoplasma gondii alpha/beta hydrolase fold domain-containing protein 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable lipase/esterase LipN 0.0204 0.0066 0.5
Mycobacterium ulcerans lipase LipI 0.0204 0.0066 0.5
Treponema pallidum N-acetylphosphinothricin-tripetide-deacetylase 0.0204 0.0066 0.5
Mycobacterium ulcerans hypothetical protein 0.0204 0.0066 0.5
Mycobacterium ulcerans lipase/esterase LipN 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable acetyl-hydrolase/esterase LipR 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable lipase LipH 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable esterase LipC 0.0204 0.0066 0.5
Leishmania major ecotin, putative 0.0204 0.0066 0.5
Trypanosoma brucei Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0204 0.0066 1
Mycobacterium tuberculosis Possible esterase LipW 0.0204 0.0066 0.5
Mycobacterium ulcerans membrane-bound esterase LipM 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable esterase/lipase LipF 0.0204 0.0066 0.5
Mycobacterium ulcerans lipase LipU 0.0204 0.0066 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0204 0.0066 0.5
Trichomonas vaginalis Esterase, putative 0.0204 0.0066 0.5
Trichomonas vaginalis Esterase, putative 0.0204 0.0066 0.5
Trypanosoma cruzi Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0204 0.0066 0.5
Toxoplasma gondii alpha/beta hydrolase fold domain-containing protein 0.0204 0.0066 0.5
Mycobacterium tuberculosis Possible lipase LipU 0.0204 0.0066 0.5
Echinococcus multilocularis hormone sensitive lipase 1.2041 1 0.5
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0204 0.0066 0.0066
Trypanosoma cruzi Alpha/beta hydrolase domain-containing protein 0.0204 0.0066 0.5
Schistosoma mansoni hormone-sensitive lipase (S09 family) 1.2041 1 1
Mycobacterium ulcerans acetyl hydrolase MbtJ 0.0204 0.0066 0.5
Mycobacterium ulcerans esterase/lipase 0.0204 0.0066 0.5
Trypanosoma cruzi Isoprenylcysteine alpha-carbonyl methylesterase, putative 0.0204 0.0066 0.5
Mycobacterium ulcerans lipase LipH 0.0204 0.0066 0.5
Mycobacterium tuberculosis Probable esterase LipM 0.0204 0.0066 0.5
Trypanosoma cruzi serine peptidase, Clan SC, Family S9D 0.0204 0.0066 0.5
Mycobacterium ulcerans esterase LipC 0.0204 0.0066 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 2.7 uM Inhibitory concentration against HIV-1 integrase by strand transfer method ChEMBL. 9083480
IC50 (binding) = 2.7 uM Inhibitory concentration against HIV-1 integrase by strand transfer method ChEMBL. 9083480
IC50 (binding) = 3.4 uM Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method ChEMBL. 9083480
IC50 (binding) = 3.4 uM Inhibitory concentration to inhibit HIV-1 integrase by 3' -processing method ChEMBL. 9083480

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.